Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis
Abstract
A 7-day course of doxycycline was superior to single-dose azithromycin in the treatment of rectal chlamydia infection among men who have sex with men. (Funded by the National Health and Medical Research Council; RTS Australian New Zealand Clinical Trials Registry number, ACTRN12614001125617.).
Keywords
australia
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
adult
male
Comparative Study
Randomized Controlled Trial
Double-Blind Method
anti-bacterial agents / adverse effects
anti-bacterial agents / administration & dosage
intention to treat analysis
anti-bacterial agents / therapeutic use*
nucleic acid amplification techniques
chlamydia infections / drug therapy*
doxycycline / adverse effects
doxycycline / therapeutic use*
doxycycline / administration & dosage
azithromycin / administration & dosage
azithromycin / therapeutic use*
homosexuality
azithromycin / adverse effects
chlamydia trachomatis / isolation & purification*
pmid:34161706
doi:10.1056/nejmoa2031631
andrew lau
fabian y s kong
jane s hocking
asymptomatic infections
rectal diseases / drug therapy*
rectal diseases / microbiology
rectum / microbiology
Access
Citation
ID:
268003
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
268003
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet